Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2007 | 06-2007 | 03-2007 | 12-2006 | 09-2006 | |
| Sales | 594,706 | 603,005 | 671,605 | 621,162 | 440,493 |
| Cost of Goods | 346,420 | 360,438 | 424,720 | 409,973 | 257,896 |
| Gross Profit | 248,286 | 242,567 | 246,885 | 211,189 | 182,597 |
| Operating Expenses | 186,609 | 177,258 | 185,679 | 687,856 | 134,202 |
| Operating Income | 62,097 | 65,747 | 61,926 | -475,694 | 49,291 |
| Interest Expense | 10,125 | 11,475 | 13,876 | 11,645 | 3,814 |
| Other Income | 3,413 | 3,156 | 3,603 | 6,137 | 9,376 |
| Pre-tax Income | 55,385 | 57,428 | 51,653 | -481,202 | 54,853 |
| Income Tax | 20,779 | 21,019 | 20,041 | 7,759 | 20,460 |
| Net Income Continuous | 34,606 | 36,409 | 31,612 | -488,961 | 34,393 |
| Net Income | $34,606 | $36,409 | $31,612 | $-488,961 | $34,393 |
| EPS Basic Total Ops | 0.34 | 0.36 | 0.31 | -4.81 | 0.34 |
| EPS Basic Continuous Ops | 0.34 | 0.36 | 0.31 | -4.80 | 0.34 |
| EPS Diluted Total Ops | 0.31 | 0.33 | 0.29 | -4.76 | 0.31 |
| EPS Diluted Continuous Ops | 0.29 | 0.31 | 0.27 | -4.73 | 0.30 |
| EBITDA(a) | $125,669 | $129,398 | $123,888 | $-415,968 | $101,141 |